Skip to content

Released May 6, 2025, before the open

10-Q filed May 6, 2025, 36 days after period end · 0000950170-25-063956

Q1 2025 · 10-Q
Revenue$193.65M+2.7% vs Q1 2024−10.2% vs Q4 2024
Net Income-$53.09MN/M vs Q1 2024N/M vs Q4 2024
EPS Diluted-$1.35N/M vs Q1 2024no prior Q4 2024 on file
Gross Profit$121,619,000−4.4%
Operating Income-$48,873,000N/M
Operating Cash Flow-$18,391,000N/M
Free Cash Flowderived-$25,127,000N/M
Margins · derived
Gross margin62.8%−4.7 pt vs Q1 2024
Operating margin-25.2%−9.7 pt vs Q1 2024
Net margin-27.4%−8.3 pt vs Q1 2024

What the release said

The release

Same quarter

MetricQ1 2025Q1 2024Q1 2023Q1 2022
Revenue$193.65M$188.61M$175.20M$106.42M
Net Income-$53.09M-$36.02M-$60.94M-$4.46M
EPS Diluted-$1.35-$0.95-$1.71-$0.22

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR